Home/Filings/4/0001104659-21-114301
4//SEC Filing

DST Capital LLC 4

Accession 0001104659-21-114301

CIK 0001563665other

Filed

Sep 8, 8:00 PM ET

Accepted

Sep 9, 7:13 PM ET

Size

8.6 KB

Accession

0001104659-21-114301

Insider Transaction Report

Form 4
Period: 2021-09-01
Transactions
  • Purchase

    Warrant (right to buy)

    2021-09-01+250,000250,000 total
    Exercise: $2.00From: 2021-09-01Exp: 2026-09-01Common Stock (250,000 underlying)
  • Purchase

    Common Stock

    2021-09-01$2.00/sh+500,000$1,000,0003,650,000 total
Holdings
  • Common Stock

    (indirect: Owned by sole member of reporting person)
    30,722
Footnotes (1)
  • [F1]On September 1, 2021, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 500,000 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 250,000 shares of common stock with an exercise price of $2.00 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $1,000,000.

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001727656

Filing Metadata

Form type
4
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 7:13 PM ET
Size
8.6 KB